![Pharmaceutics | Free Full-Text | Enhancing Dissolution and Oral Bioavailability of Ursodeoxycholic Acid with a Spray-Dried pH-Modified Extended Release Formulation Pharmaceutics | Free Full-Text | Enhancing Dissolution and Oral Bioavailability of Ursodeoxycholic Acid with a Spray-Dried pH-Modified Extended Release Formulation](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-01037/article_deploy/html/images/pharmaceutics-14-01037-ag.png)
Pharmaceutics | Free Full-Text | Enhancing Dissolution and Oral Bioavailability of Ursodeoxycholic Acid with a Spray-Dried pH-Modified Extended Release Formulation
![Frontiers | Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome Frontiers | Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome](https://www.frontiersin.org/files/Articles/401908/fphar-09-01382-HTML/image_m/fphar-09-01382-g001.jpg)
Frontiers | Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
![Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels | American Journal of Physiology-Gastrointestinal and Liver Physiology Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels | American Journal of Physiology-Gastrointestinal and Liver Physiology](https://journals.physiology.org/cms/10.1152/ajpgi.00125.2021/asset/images/medium/gi-00125-2021r01.png)
Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels | American Journal of Physiology-Gastrointestinal and Liver Physiology
![Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study | Scientific Reports Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-53999-1/MediaObjects/41598_2019_53999_Fig1_HTML.png)
Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study | Scientific Reports
![Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans](https://static-02.hindawi.com/articles/grp/volume-2012/159438/figures/159438.fig.001.jpg)
Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans
![Amazon.com: Jarrow Formulas High Potency Bile Acid Factors Formula, Supports Digestion and Absorption of Fats & Fat-Soluble Nutrients, 30 Servings, White, Vanilla, 120 Count : Health & Household Amazon.com: Jarrow Formulas High Potency Bile Acid Factors Formula, Supports Digestion and Absorption of Fats & Fat-Soluble Nutrients, 30 Servings, White, Vanilla, 120 Count : Health & Household](https://m.media-amazon.com/images/I/61D8lm-i8oS.jpg)
Amazon.com: Jarrow Formulas High Potency Bile Acid Factors Formula, Supports Digestion and Absorption of Fats & Fat-Soluble Nutrients, 30 Servings, White, Vanilla, 120 Count : Health & Household
![Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin - Nano Market Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin - Nano Market](https://nano.market/wp-content/uploads/2021/10/47517-metabolic-and-immunomodulatory-control-of-type-1-diabetes-via-orally-delivered-bile-acid-polymer-nanocarriers-of-insulin-or-rapamycin.png)
Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin - Nano Market
![New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827815001336-gr2.jpg)
New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect
![Biomolecules | Free Full-Text | Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart Biomolecules | Free Full-Text | Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart](https://www.mdpi.com/biomolecules/biomolecules-08-00159/article_deploy/html/images/biomolecules-08-00159-ag.png)
Biomolecules | Free Full-Text | Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart
The canadian multicenter doubleâ•'blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
![Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease. - Abstract - Europe PMC Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6817734/bin/mv-v25-610-f1.jpg)
Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease. - Abstract - Europe PMC
![Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway | Molecular Pharmacology Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway | Molecular Pharmacology](https://molpharm.aspetjournals.org/content/molpharm/91/2/110/F1.large.jpg)